View Older Stories View More Recent Stories
-
CLASS ACTION ALERT: Viatris Inc. Investors are Alerted to Contact BFA Law about the Pending Class Action before the June 3 Deadline
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
INVESTOR REMINDER: Berger Montague Notifies Viatris (VTRS) Investors of a Class Action Lawsuit and Deadline
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS LEGAL UPDATE: Viatris Inc. Investors are Notified that the Class Action Deadline is set to Expire on June 3
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
Viatris Inc (VTRS) Files sNDA to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS INVESTORS: Investors that Suffered Losses on Viatris Inc. are Alerted to Contact BFA Law before June 3 Class Action Deadline
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VTRS INVESTOR NOTICE: Viatris Inc. Investors are Notified to Contact BFA Law about how to Potentially Recover Losses in Class Action Lawsuit
-
ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS INVESTOR REMINDER: Viatris Inc. Investors have until June 3 to Contact BFA Law about the Securities Fraud Class Action
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS INVESTOR DEADLINE: Viatris, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Increasing unusual call option volume: VTRS HTZ HDB MP TSLY IGT FTI HMY OMC EXC
-
VIATRIS INC. (VTRS) Investors with Losses are Notified to Contact BFA Law before June 3 Court Deadline
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS STOCK UPDATE: Viatris Inc. Investors are Reminded to Contact BFA Law before Expiration of the June 3 Class Action Deadline
-
Viatris Inc (VTRS) Appoints Hemanth J. Varghese as Chief Strategy Officer
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS STOCK ALERT: BFA Law Alerts Viatris Inc. Investors of the June 3 Class Action Deadline
-
Kuehn Law Encourages Investors of Viatris Inc. to Contact Law Firm
-
VTRS CLASS REMINDER: Viatris Inc. Investors are Reminded to Contact BFA Law about the Pending Class Action by the June 3 Court Deadline
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
VTRS FRAUD ALERT: Viatris Inc. Investors are Notified to Contact BFA Law by June 3 about Filed Securities Fraud Lawsuit
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Viatris Inc (VTRS) Issues Statement on Nationwide Settlement to Resolve Opioid-Related Claims
-
ROSEN, A LEADING NATIONAL FIRM, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - VTRS
-
Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility - Hagens Berman
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
Viatris (VTRS) PT Lowered to $13 at Jefferies
-
Viatris (VTRS) PT Lowered to $10 at Piper Sandler
-
Increasing unusual call option volume: VTRS SRE LZ CNX SABR ATEC NICE ERJ COMM SEAT
-
Viatris Inc (VTRS) Misses Q4 EPS by 4c, provides guidance
-
Viatris Inc (VTRS) Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
-
Viatris Inc (VTRS) Tops Q3 EPS by 7c
-
Viatris Inc (VTRS) Tops Q3 EPS by 7c, reaffirms guidance

